For patients  /  Arthritis
Arthritis condition hub

Arthritis clinical trials, explained for patients.

What's new in arthritis research this year, how to take part in studies, and where to find financial, disability, and community support. Built around resources from Arthritis Canada and the arthritis patient community.

Free, private, no obligation at any step.

First things first: trials are specific to your type of arthritis

Rheumatoid arthritis (RA) An autoimmune condition where the immune system attacks the joints. Trials often test new ways to calm that immune response.
Osteoarthritis (OA) Wear-related breakdown of joint cartilage over time. Trials focus on pain relief, joint repair, and slowing cartilage loss.
Psoriatic arthritis (PsA) Joint inflammation connected to psoriasis. Trials often test targeted medications for both skin and joint symptoms.

Not sure which type you have? Ask your rheumatologist — they can confirm your diagnosis and tell you which trials apply to you.

Reasons for hope

What's new in arthritis research this year

Four developments from 2026 worth knowing about, spanning all three major types of arthritis, in plain language:

Phase 3 · RESET-RA trial Rheumatoid arthritis

Vagus nerve stimulation

A non-drug treatment option

A small device implanted under the skin that sends gentle electrical pulses through a nerve in the neck to calm the immune response — no drugs involved. Patients who hadn't improved enough on standard RA injectable medications saw meaningful improvement that held through the full 12-month follow-up.

Published in Nature Medicine →
Stanford Medicine Osteoarthritis

Cartilage regeneration

Regrowing what was thought to be lost for good

Researchers found a way to regrow lost cartilage in human samples, with potential to reverse cartilage loss and prevent osteoarthritis after joint injuries.

Read the research summary →
Duke Health Osteoarthritis

Joint repair at the source

Approaching first-in-human trials

A milestone toward a treatment that helps the body repair damaged joint tissue at the source, moving closer to first-in-human trials for osteoarthritis.

Read the Duke Health announcement →
Phase 2 · ARGO trial Psoriatic arthritis

Sonelokimab

Strong results for active psoriatic arthritis

A highly targeted medicine that blocks two specific proteins responsible for driving the joint and skin inflammation in psoriatic arthritis. Up to 61% of patients reached very low levels of inflammation at six months.

Published in Nature Medicine →
The basics

How arthritis clinical trials work

Clinical trials move through phases, each testing something different before a treatment can reach patients broadly:

Phase 1 Roughly 20–100 people

A small group — often including healthy volunteers alongside people with arthritis — tests safety, tolerability, and dosing. It's the first time the treatment is given to people.

Phase 2 100–300 people

Tests whether the treatment actually works, while continuing to monitor safety and side effects.

Phase 3 300 to several thousand

A large, diverse group confirms effectiveness, often comparing against a standard treatment or placebo. Usually the step required before regulatory approval.

Phase 4 After approval

The treatment is monitored in real-world use for long-term safety and rare side effects.

In every phase, three things stay constant: an informed consent process (a full explanation of purpose, risks, and benefits before you agree to participate), regular monitoring visits, and your right to withdraw at any time.
Decoding the fine print

What eligibility criteria mean

Every trial lists two kinds of rules. Here's how to read them:

Inclusion criteria

Traits most trials require you to have
  • A confirmed arthritis diagnosis
  • A specific type (RA, OA, or PsA)
  • A certain disease activity level
  • Specific prior treatments

Exclusion criteria

Traits that might rule you out of a specific trial
  • Certain other health conditions
  • Certain current medications
  • Pregnancy
  • Lab values outside a safe range
Worth repeating: these rules exist to protect participant safety and to keep the study's results reliable. They are not a judgment on you, and not qualifying for one trial doesn't mean you won't qualify for another.
You're not doing this alone

Trusted arthritis resources

Support for the whole journey: learning, funding, and community.

Learn about arthritis

From Arthritis Canada and the arthritis patient community

Financial & disability support

Programs that can ease the cost of care

Community & emotional support

People and programs that understand this condition
Before your first call

Tips for getting started

  • Found something on MyTrials that looks right? Your next step is your rheumatologist. Print or share the trial details and ask: "Is this worth exploring for me?" Doctors take patient-initiated trial questions seriously, and yours knows your history.
  • Contact the trial team with your information ready: your current medications, recent lab results, and a brief history of treatments you've tried. That's the first thing every coordinator asks for.
  • Use the tools below before your first call. The prep sheet, checklist, and consent guide were built for exactly this moment. Good trial teams expect these questions.

The 9-question checklist

The questions to ask any trial team before joining, with space to write their answers.

Download

Appointment prep sheet

One page to organize your medications, history, and questions before a screening visit.

Download

Consent form review sheet

A guided worksheet for reading a consent document at home before signing anything.

Download
The research updates and resources on this page are for information only and are not medical advice. Always talk to your rheumatologist or care team before enrolling in any trial.

See which arthritis trials fit your situation

Answer a few questions about your arthritis, your treatments, and where you live. We'll show you what's recruiting, in plain language.

Free for patients. Private. No obligation at any step.